MET and central nervous system cancer: The crosstalk signaling molecules of EGFR and MET pathways (p-AKT, p-p38, p-STAT3 and p-p65) were also mitigated by BIP-MPC-NP in TMZ-resistant glioma cells (Supplementary Fig. 7d).